Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Medtronic to resume German CoreValve sales
Medtronic says a German court lifted the ban on sales there of its CoreValve replacement heart valve, meaning it can resume sales of the transcatheter aortic valve implant as soon as it posts a roughly $6.7 million bond.
2. FLASH: FDA approves NeuroPace’s anti-epilepsy implant
California medical device maker NeuroPace lands FDA approval for its implantable neurostimulator for treatment of drug-resistant epilepsy.
1. Medical device tax: Why low Obamacare enrollment numbers cut a hole in the argument against repeal
The argument for the medical device tax was the windfall medtech companies could expect from the newly insured. What do anemic enrollment numbers for healthcare reform mean for the argument against repealing the levy?
Read more
